Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about OVERVIEW: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
OVERVIEW is a gene implicated in neurodegeneration research. Key relationships include: therapeutic target, regulates, activates. Associated with ALS, Aging, Als. Connected to 1351 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | OVERVIEW |
| Pathways | Adaptive Immunity, Akt, Angiogenesis, Apoptosis, Autophagy |
| GeneCards | OVERVIEW |
| Human Protein Atlas | OVERVIEW |
| Associated Diseases | Addiction, aging, Als, Alzheimer |
| Interactions | ACETYL-COA, Actin, AGING, AKT, ALS, ALZHEIMER |
| KG Connections | 2137 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
OVERVIEW["OVERVIEW"] -->|"biomarker for"| Cancer["Cancer"]
OVERVIEW["OVERVIEW"] -->|"biomarker for"| Neurodegeneration["Neurodegeneration"]
OVERVIEW["OVERVIEW"] -->|"biomarker for"| Ms["Ms"]
OVERVIEW["OVERVIEW"] -->|"therapeutic target"| Cancer_1["Cancer"]
OVERVIEW["OVERVIEW"] -->|"therapeutic target"| Neurodegeneration_2["Neurodegeneration"]
OVERVIEW["OVERVIEW"] -->|"therapeutic target"| Stroke["Stroke"]
IDH1["IDH1"] -->|"biomarker for"| OVERVIEW["OVERVIEW"]
TERT["TERT"] -->|"biomarker for"| OVERVIEW["OVERVIEW"]
JUN["JUN"] -->|"biomarker for"| OVERVIEW["OVERVIEW"]
CIC["CIC"] -->|"biomarker for"| OVERVIEW["OVERVIEW"]
style OVERVIEW fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Alzheimer | associated_with | disease | 1.00 |
| Cancer | associated_with | disease | 1.00 |
| Aging | associated_with | disease | 1.00 |
| Inflammation | associated_with | disease | 1.00 |
| Als | associated_with | disease | 1.00 |
| Parkinson | associated_with | disease | 1.00 |
| Tumor Microenvironment | therapeutic_target | pathway | 1.00 |
| NEUROINFLAMMATION | therapeutic_target | gene | 1.00 |
| Mtor | therapeutic_target | pathway | 1.00 |
| Neurodegeneration | associated_with | disease | 1.00 |
| Tumor | treats | disease | 1.00 |
| CANCER | biomarker_for | gene | 1.00 |
| Cancer | treats | disease | 1.00 |
| Immunotherapy | therapeutic_target | pathway | 1.00 |
| Epigenetic | therapeutic_target | pathway | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| Immune Response | therapeutic_target | pathway | 1.00 |
| Als | treats | disease | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| Tumor | regulates | disease | 1.00 |
| Stem Cell | therapeutic_target | pathway | 1.00 |
| Cardiovascular | therapeutic_target | disease | 1.00 |
| CANCER | regulates | gene | 1.00 |
| Neuroinflammation | therapeutic_target | disease | 1.00 |
| Aging | therapeutic_target | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Drug Resistance | therapeutic_target | pathway | 1.00 |
| Metastasis | therapeutic_target | pathway | 1.00 |
| Cancer | regulates | disease | 1.00 |
| Immune Response | regulates | pathway | 1.00 |
| Oxidative Stress | therapeutic_target | pathway | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Stroke | therapeutic_target | disease | 1.00 |
| Cancer | biomarker_for | disease | 1.00 |
| Fibrosis | therapeutic_target | disease | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| GENES | therapeutic_target | gene | 1.00 |
| Diabetes | therapeutic_target | disease | 1.00 |
| Als | regulates | disease | 1.00 |
| Autophagy | regulates | pathway | 1.00 |
| Differentiation | therapeutic_target | pathway | 1.00 |
| Inflammation | regulates | disease | 1.00 |
| Apoptosis | therapeutic_target | pathway | 1.00 |
| Autoimmune | therapeutic_target | disease | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| Alzheimer | therapeutic_target | disease | 1.00 |
| Inflammation | therapeutic_target | disease | 1.00 |
| Obesity | associated_with | disease | 1.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| companies-ari-bio | describes | wiki_page | 1.00 |
| AKT | therapeutic_target | gene | 1.00 |
| mechanisms-epitranscriptomics-rna-modifications-cbs-psp | describes | wiki_page | 1.00 |
| OXIDATIVE STRESS | therapeutic_target | gene | 1.00 |
| companies-astrazeneca | describes | wiki_page | 1.00 |
| INFLAMMATION | regulates | gene | 1.00 |
| GENES | therapeutic_target | gene | 1.00 |
| companies-alzecure-pharma | describes | wiki_page | 1.00 |
| APOPTOSIS | therapeutic_target | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| INFLAMMATION | therapeutic_target | gene | 1.00 |
| clinical-trials-circuit-based-dbs-nct05658302 | describes | wiki_page | 1.00 |
| AUTOPHAGY | regulates | gene | 1.00 |
| CANCER | regulates | gene | 1.00 |
| companies-annovis-bio | describes | wiki_page | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| events | describes | wiki_page | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| MIRNAS | regulates | gene | 1.00 |
| CANCER | associated_with | gene | 1.00 |
| PI3K | therapeutic_target | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| PARKINSON | associated_with | gene | 1.00 |
| MITOCHONDRIAL DYSFUNCTION | therapeutic_target | gene | 1.00 |
| AGING | associated_with | gene | 1.00 |
| ALZHEIMER | activates | gene | 1.00 |
| ALZHEIMER | associated_with | gene | 1.00 |
| AUTOPHAGY | associated_with | gene | 1.00 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 1.00 |
| OXIDATIVE STRESS | activates | gene | 1.00 |
| ALZHEIMER | therapeutic_target | gene | 1.00 |
| STROKE | therapeutic_target | gene | 0.90 |
| GENES | regulates | gene | 0.90 |
| AKT | regulates | gene | 0.90 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.90 |
| GENES | associated_with | gene | 0.90 |
| INFLAMMATION | associated_with | gene | 0.90 |
| AUTOPHAGY | therapeutic_target | gene | 0.90 |
| PARKINSON'S DISEASE | associated_with | gene | 0.90 |
| NF-ΚB | regulates | gene | 0.90 |
| APOPTOSIS | associated_with | gene | 0.90 |
| CYTOKINES | activates | gene | 0.80 |
| ALZHEIMER | regulates | gene | 0.80 |
| NEURODEGENERATIVE DISORDERS | regulates | gene | 0.80 |
| AKT | associated_with | gene | 0.80 |
| ALZHEIMER'S DISEASE | regulates | gene | 0.80 |
| ASTROCYTES | therapeutic_target | gene | 0.80 |
| RAS | therapeutic_target | gene | 0.80 |
| NEURODEGENERATION | regulates | gene | 0.80 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning OVERVIEW in their description or question text
No additional research found